Weerasinghe Rohan 4

What Happened

Rohan Weerasinghe, a director of PHINIA Inc. (PHIN), received a grant of 41 deferred restricted stock units (DRSUs) on March 20, 2026. The award was recorded as a derivative acquisition at $0.00 per unit (transaction code A), so there was no cash purchase or sale. DRSUs represent the economic equivalent of common shares but are subject to vesting and settlement terms.

Key Details

• Transaction date: 2026-03-20; Filing date (Accession): 2026-03-24 (timely filing).
• Transaction type/code: Grant/Award (A); 41 DRSUs acquired at $0.00 per unit.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnote F1: Each DRSU equals one share economically and vests on the one-year anniversary of the grant; settlement into shares (including dividend-equivalent DRSUs) occurs upon the reporting person’s termination of board service under the Director Deferred Compensation Program and 2023 Stock Incentive Plan.
• Footnote F2: Some or all DRSUs reflect automatic reinvestment of dividend equivalents on outstanding DRSUs as required by the award terms.
• Derivative disclosure: This was a grant of restricted units (not an open-market buy or sale).

Context

DRSUs are a form of deferred compensation for directors and do not indicate an immediate purchase or sale of stock; they generally vest over time and convert to shares according to plan rules. Because the units were granted at no cost and are subject to vesting/settlement conditions, this is routine compensation rather than a direct bullish investment signal.